4//SEC Filing
Swisher Daniel N JR 4
Accession 0001193125-25-201534
CIK 0001088856other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 8:38 PM ET
Size
8.2 KB
Accession
0001193125-25-201534
Insider Transaction Report
Form 4
Swisher Daniel N JR
Director
Transactions
- Sale
Common Stock
2025-09-10$72.45/sh−2,200$159,390→ 0 total - Exercise/Conversion
Stock option (right to buy)
2025-09-10−2,200→ 3,300 totalExercise: $14.08Exp: 2028-08-20→ Common Stock (2,200 underlying) - Exercise/Conversion
Common Stock
2025-09-10$14.08/sh+2,200$30,976→ 2,200 total
Footnotes (2)
- [F1]The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on August 1, 2024 in effect at the time of this transaction.
- [F2]Fully exercisable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001323113
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 8:38 PM ET
- Size
- 8.2 KB